Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BONADIUV: Ibandronate for Bone Health in Breast Cancer
NCT02616744Phase 2Completed
- Sponsor
- Azienda Ospedaliero-Universitaria Careggi
- Start
- Jan 2011
- Primary completion
- May 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ibandronic acid in osteopenia, sponsored by Azienda Ospedaliero-Universitaria Careggi. Started Jan 2011; status: completed.
02
Drugs
ibandronic acid
03
Conditions
osteopenia
Beyond the preview
Go deeper on NCT02616744.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02616744.